Literature DB >> 15266245

Conference report--at the forefront of cancer research: clinical results highlights of the annual meeting of the 95th American Association for Cancer Research, March 27-31, 2004; Orlando, Florida.

Sara M Mariani.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15266245      PMCID： PMC1395772     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  16 in total

1.  Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  Michelle L Reyzer; Yunsheng Hsieh; Kwokei Ng; Walter A Korfmacher; Richard M Caprioli
Journal:  J Mass Spectrom       Date:  2003-10       Impact factor: 1.982

Review 2.  Kidney cancer: the Cytokine Working Group experience (1986-2001): part I. IL-2-based clinical trials.

Authors:  M B Atkins; J Dutcher; G Weiss; K Margolin; J Clark; J Sosman; T Logan; F Aronson; J Mier
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

3.  Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression.

Authors:  Sarah A Schwartz; Robert J Weil; Mahlon D Johnson; Steven A Toms; Richard M Caprioli
Journal:  Clin Cancer Res       Date:  2004-02-01       Impact factor: 12.531

4.  Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.

Authors:  Robert J Motzer; Jennifer Bacik; Lawrence H Schwartz; Victor Reuter; Paul Russo; Stephanie Marion; Madhu Mazumdar
Journal:  J Clin Oncol       Date:  2004-02-01       Impact factor: 44.544

5.  Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry.

Authors:  David B Friedman; Salisha Hill; Jeffrey W Keller; Nipun B Merchant; Shawn E Levy; Robert J Coffey; Richard M Caprioli
Journal:  Proteomics       Date:  2004-03       Impact factor: 3.984

6.  Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial.

Authors:  Joseph I Clark; Michael B Atkins; Walter J Urba; Steven Creech; Robert A Figlin; Janice P Dutcher; Larry Flaherty; Jeffrey A Sosman; Theodore F Logan; Richard White; Geoffrey R Weiss; Bruce G Redman; Christopher P G Tretter; David McDermott; John W Smith; Michael S Gordon; Kim A Margolin
Journal:  J Clin Oncol       Date:  2003-06-16       Impact factor: 44.544

7.  Proteomic patterns of tumour subsets in non-small-cell lung cancer.

Authors:  Kiyoshi Yanagisawa; Yu Shyr; Baogang J Xu; Pierre P Massion; Paul H Larsen; Bill C White; John R Roberts; Mary Edgerton; Adriana Gonzalez; Sorena Nadaf; Jason H Moore; Richard M Caprioli; David P Carbone
Journal:  Lancet       Date:  2003-08-09       Impact factor: 79.321

Review 8.  Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics.

Authors:  Masayuki Takahashi; Jun Sugimura; Ximing Yang; Nicholas Vogelzang; Bin S Teh; Kyle Furge; Bin T Teh
Journal:  Adv Cancer Res       Date:  2003       Impact factor: 6.242

Review 9.  Interleukin-2: clinical applications.

Authors:  Michael B Atkins
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

10.  Playing Tag with HIF: The VHL Story.

Authors:  Sherri K. Leung; Michael Ohh
Journal:  J Biomed Biotechnol       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.